Michael F Grunebaum
8PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 06, 2025
Clinical trials since 2020 of rapid anti-suicidal ideation effects of ketamine and its enantiomers: a systematic review.Sumra Sajid, J John Mann, Michael F Grunebaum
|Sep 07, 2022
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators.Rebecca B Price, Nicholas Kissel, Andrew Baumeister
|Jun 27, 2022
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis.Gustavo C Medeiros, Todd D Gould, William L Prueitt
|Mar 07, 2019
Correction: Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression.Wei Guo, Rodrigo Machado-Vieira, Sanjay Mathew
|Dec 16, 2018
Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression.Wei Guo, Rodrigo Machado-Vieira, Sanjay Mathew
|Apr 29, 2017
Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial.Michael F Grunebaum, Steven P Ellis, John G Keilp
Pageof 2
Frequent Collaborators
3 joint publications
J John Mann
2 joint publications
Wei Guo
2 joint publications
Francis J McMahon
1 joint publications
Leo Sher
1 joint publications
Gustavo C Medeiros
1 joint publications
Nuri B Farber
1 joint publications
Balwinder Singh
1 joint publications
Sudhakar Selvaraj
1 joint publications
Eric D Achtyes
1 joint publications
Mark A Frye
